Selventa

Selventa Announces a Joint Technology Collaboration with Pfizer Inc., to Include Developing Knowledge-sharing Portal of Biological Networks for the Scientific Community

Selventa Announces a Joint Technology Collaboration with Pfizer Inc., to Include Developing Knowledge-sharing Portal of Biological Networks for the Scientific Community

March 28, 2011

CAMBRIDGE, Mass. – March 28, 2011 – SelventaTM today announced a continuation and expansion of its strategic partnership with the world’s largest pharmaceutical company, Pfizer Inc., in the areas of biological knowledge dissemination and drug safety.

Advanced Electron Beams, Inc

Advanced Electron Beams Introduces 2nd ITB Electron Beam Emitter for Aseptic Bottle Filling

Advanced Electron Beams Introduces 2nd ITB Electron Beam Emitter for Aseptic Bottle Filling

March 24, 2011

 

WILMINGTON, Mass., March 24, 2011 – Advanced Electron Beams (AEB), a leading provider of electron beam technology, today announced the introduction of the e16ITB emitter, their second “in the bottle” product for sterilizing PET and HDPE bottles. The e16ITB was designed specifically for the Asian market where the bottle geometries require a narrow nozzle emitter. Concurrent with this product announcement, AEB also announced that they have entered into a strategic agreement with a leading Japanese equipment OEM.

Accuri Cytometers, Inc.

BD Completes Acquisition of Accuri Cytometers, Inc.

BD Completes Acquisition of Accuri Cytometers, Inc.

March 18, 2011

FRANKLIN LAKES, N.J., March 18, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.

The acquisition expands BD's presence into the emerging affordable personal flow cytometer space, and helps expand the use of flow cytometry technology by researchers in regions of the world where ease of use and affordability are critical.

Flagship VentureLabs Spawns New Cos. Essentient, Permeon Biologics

Flagship VentureLabs Spawns New Cos. Essentient, Permeon Biologics

March 16, 2011

Flagship Ventures is taking aim at the fields of nutrition and intracellular therapy through two new start-ups it has created: Essentient Inc. and Permeon Biologics Inc.

The firm formed them through its VentureLabs effort, in which it works with experts in biological and physical sciences to target new markets.

Celexion LLC

BioAmber and CELEXION Announce Exclusive Licensing Partnership

BioAmber and CELEXION Announce Exclusive Licensing Partnership

March 15, 2011

MINNEAPOLIS, MN, March 15 /PRNewswire/ - BioAmber, the market leader in biobased succinic acid, has entered into an exclusive licensing agreement with CELEXION LLC for technology related to the production of adipic acid and other chemical intermediates. The current market for adipic acid is close to 3 million tons per year, worth approximately $8 billion at current market prices.

Flagship's Noubar Afeyan quoted in New York Times story, "Alt-Fuel Hopefuls Make Plays for Oil Companies' Cash"

Flagship's Noubar Afeyan quoted in New York Times story, "Alt-Fuel Hopefuls Make Plays for Oil Companies' Cash"

March 11, 2011

 "...Joule Unlimited of Cambridge, Mass., introduced potential investors here to a process they say can convert sunlight directly into diesel fuel through specially cultured microorganisms."

Click NY Times logo to view entire article.

MIT’s Technology Review Unveils 2011 TR50 List of the World’s Most Innovative Companies

MIT’s Technology Review Unveils 2011 TR50 List of the World’s Most Innovative Companies

February 22, 2011

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Technology Review today announced the 2011 TR50, the second annual list of the world’s most innovative technology companies. In selecting the TR50, the editors of Technology Review look for companies that are setting the agenda in an increasingly important market, on the verge of disrupting an established market, or creating an entirely new market. Spanning energy, computing, the Web, biomedicine, and materials, the companies on the list are using their inventions to reshape their industries and to transform how we live.

Quanterix Corporation

Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability

Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability

February 23, 2011

CAMBRIDGE, MA – February 23, 2011– Quanterix Corporation, a single molecule diagnostics company providing technology with unprecedented sensitivity for the life science and in vitro diagnostics markets, today announced the online publication of a study that builds upon the company’s Single Molecule Array (SiMoA™) technology by combining digital and analog detection in one straightforward measurement.

Quanterix Corporation

Quanterix Announces New Technology Evaluation Agreement

Quanterix Announces New Technology Evaluation Agreement

February 22, 2011

CAMBRIDGE, MA – February 22, 2011 – Quanterix Corporation, enabling a new generation of diagnostic tests based on revolutionary Single Molecule Array (SiMoA™) technology, today announced that it has entered into an evaluation agreement with Novartis Diagnostics on the potential use of Quanterix’s SiMoA platform technology for diagnostic use. The evaluation will be conducted at Quanterix and will focus on an undisclosed neuron-specific protein target.

Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off

Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off